TG Therapeutics Inc (TGTX) — Cash Flow-to-Debt Ratio
TG Therapeutics Inc (TGTX) has a Cash Flow-to-Debt Ratio of -0.06x as of September 2025, meaning its operating cash flow of $-23.15 Million could theoretically repay 0% of its total liabilities ($417.81 Million) in one year. See TGTX cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
TG Therapeutics Inc Cash Flow-to-Debt Ratio (1996–2024)
Historical debt coverage capacity for TG Therapeutics Inc across 29 annual periods. Also explore net asset momentum of TG Therapeutics Inc to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for TG Therapeutics Inc (1996–2024)
Year-by-year debt coverage analysis for TG Therapeutics Inc. For market capitalisation and broader financial context, see TG Therapeutics Inc (TGTX) total market value.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.11x | $-40.52 Million | $355.33 Million | ▲ +38.6% |
| 2023 | -0.19x | $-31.41 Million | $169.09 Million | ▲ +85.8% |
| 2022 | -1.31x | $-176.17 Million | $134.99 Million | ▲ +37.1% |
| 2021 | -2.07x | $-295.63 Million | $142.48 Million | ▼ -2.8% |
| 2020 | -2.02x | $-214.51 Million | $106.29 Million | ▼ -89.0% |
| 2019 | -1.07x | $-132.81 Million | $124.40 Million | ▲ +50.7% |
| 2018 | -2.16x | $-128.93 Million | $59.58 Million | ▼ -124.7% |
| 2017 | -0.96x | $-93.76 Million | $97.38 Million | ▲ +14.4% |
| 2016 | -1.12x | $-61.59 Million | $54.78 Million | ▼ -185.5% |
| 2015 | -0.39x | $-44.69 Million | $113.47 Million | ▲ +2.6% |
| 2014 | -0.40x | $-35.06 Million | $86.75 Million | ▼ -79.6% |
| 2013 | -0.22x | $-10.82 Million | $48.11 Million | ▲ +71.7% |
| 2012 | -0.80x | $-5.19 Million | $6.52 Million | ▼ -5660.2% |
| 2011 | -0.01x | $-86.58K | $6.27 Million | ▲ +83.2% |
| 2010 | -0.08x | $-1.97 Million | $24.00 Million | ▲ +44.1% |
| 2009 | -0.15x | $-1.05 Million | $7.15 Million | ▲ +81.4% |
| 2008 | -0.79x | $-4.44 Million | $5.62 Million | ▲ +85.5% |
| 2007 | -5.47x | $-10.23 Million | $1.87 Million | ▼ -37.0% |
| 2006 | -3.99x | $-7.75 Million | $1.94 Million | ▼ -6.4% |
| 2005 | -3.75x | $-6.24 Million | $1.67 Million | ▲ +21.2% |
| 2004 | -4.76x | $-5.69 Million | $1.20 Million | ▼ -33.2% |
| 2003 | -3.57x | $-3.45 Million | $966.02K | ▼ -44.1% |
| 2002 | -2.48x | $-1.43 Million | $577.73K | ▲ +71.8% |
| 2001 | -8.80x | $-4.47 Million | $508.61K | ▼ -1487.3% |
| 2000 | -0.55x | $-1.15 Million | $2.08 Million | ▲ +85.5% |
| 1999 | -3.83x | $-2.30 Million | $600.00K | ▲ +11.5% |
| 1998 | -4.33x | $-2.60 Million | $600.00K | ▲ +57.7% |
| 1997 | -10.25x | $-4.10 Million | $400.00K | ▲ +23.1% |
| 1996 | -13.33x | $-4.00 Million | $300.00K | — |